B2B ad examples

¿Eres neurólogo o neurocirujano? Este simposio es para ti 🧠 Hospital Angeles Pedregal te invita al Simposio de Movimientos Anormales, un encuentro académico para actualizar conocimientos e intercambiar experiencias sobre el abordaje de trastornos del movimiento, como la enfermedad de Parkinson, el temblor de intención y la distonía. 📅 22 de octubre de 2026 🕓 16:00 a 20:30 h 👉🏻Comparte este post con tus colegas y regístrate aquí: https://lnkd.in/gv5TsfFQ #EnfermedadDeParkinson #ActualizaciónMédica #Neurología #Neurocirugía #HospitalAngeles

Could APAC be the difference between hitting your Oncology development milestones on time... or falling six months behind? In our latest webinar, Luke S. Gill, Head of Oncology, Will Chen, Global Head of Regulatory Affairs, together with Dr. Rokoyo Nochi of EPS, explored how early integration of China and Japan into global Oncology programs can accelerate enrolment, strengthen development strategies, and reduce timeline risk. Key insights shared ; ✅ The impact of China and Japan on enrolment timelines ✅ Why APAC should be considered at protocol design, not as a rescue strategy ✅ Regulatory developments enabling more seamless global studies ✅ The role of Japan and China in accelerated Oncology development pathways Read the article and discover how a dual-engine APAC strategy could help de-risk and accelerate your next Oncology program. https://lnkd.in/euiUhqsT #OncologyTrials #ClinicalResearch #OncologyDrugDevelopment #GlobalTrials #APAC #ChinaClinicalTrials #JapanClinicalTrials #ClinicalDevelopment #CRO #EmeraldClinical

Why is AI critical in Pharmaceutical Quality Management? Discover below 👇

Cancer accounted for roughly 35% of all new FDA drug approvals in 2025. Yet progress across oncology remains uneven. Where new therapies emerge depends on more than clinical need. The biology must offer a viable point of intervention, clinical evidence must be feasible to generate, and the development path must be capable of sustaining the investment required to reach patients. Rare cancers bring these pressures into particularly sharp focus. Collectively, they account for approximately one quarter of cancer diagnoses worldwide, yeat each individual disease may affect only a small number of patients. This can make research, trial recruitment, and development more difficult even where unmet need is substantial. Orphan-drug frameworks were created to change part of that equation. Through development incentives and closer regulatory engagement, they can make focused development programs viable for patient populations that may not fit conventional large-market models. Our latest blog article examines why some areas of oncology remain underserved, how biology, clinical development, and economics interact, and how orphan-drug policy has reshaped what is possible in smaller patient populations. It also looks at one setting where these challenges converge: relapse after allogeneic stem cell transplantation in acute leukemia, an area Helix BioPharma is actively targeting through its development pipeline. Read the full article: https://lnkd.in/eQU8JGbp #Oncology #CancerResearch #CancerBiology #TranslationalMedicine #MedicalInnovation #HealthcareInnovation #FutureOfMedicine #Biotechnology #LifeSciences

Contact us today to learn how our Clinical Technology Specialist team can support your cases using your equipment >> https://lnkd.in/gUcWDyvw Utilize our per-case service model with dedicated support from our experienced Clinical Technology Specialists (CTS), who operate your equipment to ensure optimal performance during each case. Our highly trained CTS team is available to assist in the OR, running a broad array of equipment and supporting your team to help drive better patient outcomes. Consider ultrasound technology — it provides real-time imaging to visualize anatomy and guide procedures. Our Clinical Technologists are skilled in optimizing image quality and making on-the-spot adjustments to ensure the best possible visualization during surgery. #AdvancedSurgicalTechnologies #ClinicalProceduralSupport #AccessForAll

What can the right clinical supply partner help make possible for your next study? At ChinaTrials 18, R&D leaders from China, Asia-Pacific, the U.S. and Europe will come together to share ideas and build partnerships. Catalent will be there too, ready to talk about flexible, comprehensive clinical supply services that can help support your studies. Come find us at Booth #5 in Shanghai, October 28–30. We’d love to hear what you’re working on. Book a 1:1 with our experts: https://lnkd.in/dY8RcKqH #ChinaTrials #ClinicalTrials #ClinicalSupply

Cum iti dai seama ca ceea ce faci are cu adevarat sens? Pentru Elena, Farmacist Sef Dr. Max Kaufland Ferentari, raspunsul vine atunci cand un pacient se intoarce si ii spune simplu: „Mi-ai fost de ajutor.” Inspirata de mama sa, asistent medical, si-a ales profesia din dorinta de a fi aproape de oameni. Astazi, intalneste zilnic pacienti cu nevoi diferite, uneori grabiti, alteori ingrijorati, dar mereu in cautarea unui sprijin de incredere. Farmacia este adesea unul dintre primele locuri in care oamenii cauta ajutor. Uneori au nevoie de un tratament. Alteori, de un sfat, de explicatii sau de indrumare pentru preventie. Iar dincolo de cei 5 ani de studiu, de specializari si de formarea continua, ceea ce face diferenta este disponibilitatea de a fi acolo pentru ceilalti. 💚 Pentru ca, dincolo de profesie, sunt oamenii care fac diferenta. Oamenii care au GRIJA. drmaxromania.com

Você sabe reconhecer quando alguma coisa mudou nas suas mamas? 🌸 Neste vídeo, a Dra. Ana Cristina, ginecologista, explica quais alterações merecem atenção: nódulos, regiões endurecidas, mudanças na pele ou no formato da mama, retração do mamilo e secreções espontâneas. Muitas dessas alterações podem ter causas benignas, mas mudanças persistentes ou diferentes do habitual precisam ser avaliadas por um profissional. E o cuidado começa antes de qualquer sintoma. Manter o acompanhamento médico em dia permite avaliar o histórico individual, os fatores de risco e os exames indicados para cada mulher. Conheça o seu corpo e, ao perceber algo diferente, procure avaliação médica. Salve este vídeo e compartilhe com outras mulheres. #OutubroRosa #CancerDeMama #SaudeDaMulher #Prevencao #CMRPharma

Heb jij eerder als kinderverpleegkundige, obstetrieverpleegkundige, IC-verpleegkundige of operatieassistent gewerkt? En denk je er weleens over na om terug te keren naar het ziekenhuis? Misschien lijkt het je leuk om weer aan de slag te gaan in je oude vak, maar heb je nog vragen. Wat komt er kijken bij terugkeren? En welke mogelijkheden zijn er? Tijdens onze online informatiesessie op maandag 9 november van 19.00 tot 20.00 uur vertellen we je er alles over. Iets voor jou? Meld je aan via: https://lnkd.in/enXUhtiV

𝐍𝐞𝐭𝐰𝐞𝐫𝐤𝐛𝐞𝐡𝐞𝐞𝐫𝐝𝐞𝐫 𝐈𝐂𝐓 𝐠𝐞𝐳𝐨𝐜𝐡𝐭! | 𝐀𝐧𝐭𝐨𝐧𝐢𝐮𝐬 𝐒𝐧𝐞𝐞𝐤 (𝟑𝟐 - 𝟑𝟔 𝐮𝐮𝐫) Als Netwerkbeheerder ICT beheer en beveilig je de netwerkinfrastructuur van ons ziekenhuis in Sneek. Je werkt met Fortigate-firewalls, WLAN en alles daartussen. Daarnaast bouw je mee aan wat komt: we vervangen op dit moment onze accesslaag en ons datacenternetwerk. Je werkt in een klein team met korte lijnen en ruimte voor je eigen ideeën. ✅ 32–36 uur, vaste aanstelling ✅ € 3.903 – € 5.503 bruto per maand ✅ Eindejaarsuitkering en een uitgebreide onboarding 👉 Solliciteer nu!

🌍 65 countries and counting and we’ve just reached an exciting new milestone! Papua New Guinea is now part of the bookdialysis network. 🎉 We’re proud to partner with Pacific International Hospital, adding two clinics in Port Moresby and Lae and marking our first presence in Papua New Guinea. Known for its tropical climate, dramatic landscapes, remarkable biodiversity and rich cultural heritage, Papua New Guinea opens up a whole new corner of the world for people on dialysis to consider exploring. Because every new country on our network means more than another point on the map. It means more choice, more possibilities and more of the world within reach. Welcome to the bookdialysis network, Pacific International Hospital PNG . 🌏 👉https://lnkd.in/gBNeykSV

At bookdialysis, we aim to make dialysis travel simpler for patients while providing clinics with a clearer, more direct way to connect with international travellers. Through bookdialysis, patients can discover your clinic and submit treatment requests as part of their travel planning. For clinics, this means greater visibility among international patients, new opportunities to receive treatment requests and the chance to become part of a growing global network. By bringing patients and clinics closer together, we help make dialysis travel more accessible and support more people in exploring the world with confidence. Join the bookdialysis network. 👉https://lnkd.in/de3WDdbu #bookdialysis #holidaydialysis #traveldialysis

Vacature | Tender Specialist Zorgtechnologie Als Tender Specialist bij CLB verbind je klantvragen, techniek en commercie. Je vertaalt complexe aanbestedingen naar overtuigende voorstellen die zorgorganisaties helpen om betere, veiligere en toekomstbestendige zorg te bieden. Je werkt aan aanbestedingen die ertoe doen en helpt mee aan betere en toekomstbestendige zorg. ✓ Salaris tot € 4.500 bruto per maand ✓ 32–40 uur per week ✓ Hybride werken ✓ Een hecht team en volop ontwikkelmogelijkheden Klinkt dit als jouw volgende stap? 👉 Bekijk de vacature en solliciteer!

Today, Dawn Health, NVIDIA Healthcare, Microsoft for Healthcare and Merck Healthcare announce a collaboration to redefine how Patient Support Programs (PSPs) are delivered. The four-way collaboration, the first-of-its-kind within patient support services, is building an agentic care experience available to patients 24/7, personalized to each patients individual disease state, with access to a PSP nurse or healthcare provider when warranted. The detailed contributions to the four-way collaboration are as follows: • NVIDIA: AI Models and technologies • Microsoft: Cloud and AI Services • Merck: Patient insights, clinical and pharmaceutical expertise • Dawn Health: Product development and regulatory experience For people living with rare diseases and their caregivers, this means active support in their daily lives, as an extra layer beyond the point of care. Kimberly Powell, Vice President and General Manager, Healthcare at NVIDIA, will introduce this vision on today’s session, Turning AI Into the Infrastructure Advancing Human Health, happening at NVIDIA GTC, Berlin, at 2:30pm CEST. Read the full press release: https://lnkd.in/edbMidZz See you at NVIDIA GTC Berlin. _ #AgenticPSP #HealthcareAI #PatientSupport #DigitalHealth #NVIDIAGTC #MicrosoftAI #MicrosoftForStartups #HighTouchHighTech Cedric Steenbeke Constantin Landers Jesse Leung Janette Ciborowski Narges Masoudi Microsoft for Startups Sally Ann Frank Vikas Arora Andreas Palm Vesth Ran Wei Baker Emre Ozcan, PhD Berkan Aysan Jantje Rees Flávia Felix Alexander Mandix Hansen Jacob Hahn Michelsen Anne-Sofie Nielsen Michael Håkan Holti Kellezi [DHDK_MERCKRT_003_V0]

More freedom in digital denture design. 💻 With the Candulor Denture SmileLibrary+, proven Candulor tooth molds are available directly within the 3Shape® Dental System. This combines decades of prosthetic expertise with the possibilities of a modern digital workflow. The library includes 107 tooth molds for natural looking results and offers 448 possible combinations for maximum customization. It supports set up concepts based on Gerber, Gysi, TIF and physiologic occlusion, resulting in efficient and reproducible workflows. Whether for complete dentures, monolithic dentures or tooth segments, UCAN Design helps bring proven prosthetic concepts into the digital world with confidence and flexibility. 🔗 Start your free 60 day trial of UCAN Design: https://lnkd.in/eYYQbwFn

Are you working with 3Shape® and our UCAN Mill materials? Then we have good news for you: the corresponding material DMEs are now available for download on our website, making it quick and easy to integrate our materials into your digital workflow. ✅ Fast access to material data ✅ Easy integration into 3Shape® ✅ Streamlined laboratory workflows ✅ Available directly on our website ➡️ Download now and get started right away. https://lnkd.in/esavvgkF

At AMWC Dubai 2026, Galderma is showcasing its leadership in Injectable Aesthetics, with data across its comprehensive portfolio. With eight abstracts, a symposium, and Meet-the-Expert sessions, we are highlighting innovation that addresses growing needs; from menopause-related skin changes and regenerative aesthetic solutions, to body indications. Discover how Galderma is advancing the science of aesthetics through evidence-based solutions that support complex patient profiles and unmet needs. Read more: https://lnkd.in/ei9kQJgb #AdvancingDermatology #SkinSciencebyGalderma #AMWCDubai

Your healthcare data is growing. Is your infrastructure keeping up? Connecting multiple EHRs, clinical systems, and data sources shouldn't mean rebuilding your infrastructure every time you scale. Kodjin Data Platform helps healthcare organizations consolidate fragmented data into a unified, scalable foundation for interoperability, analytics, research, and AI. Explore how to make your healthcare data work across systems and use cases.

1.8 billion people menstruate every month, yet menstrual health is still underserved - with knock-on effects for participation and economic opportunity. Essity’s Tanja Grubner shares her perspective on what it means for the future of hygiene & health. Watch now.

When a resident declines, the F-tags leave two options. The facility failed, or the decline was unavoidable. To show unavoidable, you need evidence. Watch the on-demand video on what that evidence looks like, from admission on. #FTags #SNFCompliance #RiskManagement #NursingHomeQuality

Know affinity, ELISA, Olink or Somalogic platforms, but less familiar with mass spectrometry? The two work in fundamentally different ways, and that affects what each can measure. This guide explains the difference in plain terms and compares discovery MS, targeted LC-MS and IP-MS with affinity platforms across seven criteria. Download the free guide below.

How confident are you in the numbers behind your next go/no-go decision? Targeted LC-MS and affinity platforms take very different approaches to quantification, and that affects what you can compare across studies, sites and time points. This guide explains how the platforms differ on quantitation, specificity and reproducibility. Download the free guide below.

Great bedside care is not enough on its own. The standard of care also needs documentation and communication. When a family expects more than the standard of care, that gap can still lead to complaint visits and litigation. Watch the on-demand video on how to close it. #SkilledNursing #StandardOfCare #RiskManagement #SNFLeadership

Download our Capabilities Guide to explore comprehensive genomics, transcriptomics, proteomics, and analysis solutions for clinical and research applications.